» Articles » PMID: 33013826

Microtopography of Immune Cells in Osteoporosis and Bone Lesions by Endocrine Disruptors

Abstract

Osteoporosis stems from an unbalance between bone mineral resorption and deposition. Among the numerous cellular players responsible for this unbalance bone marrow (BM) monocytes/macrophages, mast cells, T and B lymphocytes, and dendritic cells play a key role in regulating osteoclasts, osteoblasts, and their progenitor cells through interactions occurring in the context of the different bone compartments (cancellous and cortical). Therefore, the microtopography of immune cells inside trabecular and compact bone is expected to play a relevant role in setting initial sites of osteoporotic lesion. Indeed, in physiological conditions, each immune cell type preferentially occupies either endosteal, subendosteal, central, and/or perisinusoidal regions of the BM. However, in the presence of an activation, immune cells recirculate throughout these different microanatomical areas giving rise to a specific distribution. As a result, the trabeculae of the cancellous bone and endosteal free edge of the diaphyseal case emerge as the primary anatomical targets of their osteoporotic action. Immune cells may also transit from the BM to the depth of the compact bone, thanks to the efferent venous capillaries coursing in the Haversian and Volkmann canals. Consistently, the innermost parts of the osteons and the periosteum are later involved by their immunomodulatory action, becoming another site of mineral reabsorption in the course of an osteoporotic insult. The novelty of our updating is to highlight the microtopography of bone immune cells in the cancellous and cortical compartments in relation to the most consistent data on their action in bone remodeling, to offer a mechanist perspective useful to dissect their role in the osteoporotic process, including bone damage derived from the immunomodulatory effects of endocrine disrupting chemicals.

Citing Articles

Integrated single-cell and bulk RNA sequencing analysis reveal immune-related biomarkers in postmenopausal osteoporosis.

Fang S, Ni H, Zhang Q, Dai J, He S, Min J Heliyon. 2024; 10(18):e38022.

PMID: 39328516 PMC: 11425179. DOI: 10.1016/j.heliyon.2024.e38022.


Exploring the genetic association between immune cells and susceptibility to osteonecrosis using large-scale population data.

Meng C, Qi B, Luo H, Tang Z, Ren J, Shi H Heliyon. 2024; 10(14):e34547.

PMID: 39130408 PMC: 11315082. DOI: 10.1016/j.heliyon.2024.e34547.


An exploration of the causal relationship between 731 immunophenotypes and osteoporosis: a bidirectional Mendelian randomized study.

Zhou D, Zi C, Gan G, Tang S, Chen Q Front Endocrinol (Lausanne). 2024; 15:1341002.

PMID: 39086903 PMC: 11288873. DOI: 10.3389/fendo.2024.1341002.


Integration of bioinformatics and machine learning approaches for the validation of pyrimidine metabolism-related genes and their implications in immunotherapy for osteoporosis.

Feng Z, Wu Z, Zhang Y BMC Musculoskelet Disord. 2024; 25(1):402.

PMID: 38778304 PMC: 11110368. DOI: 10.1186/s12891-024-07512-z.


Analysis and validation of biomarkers of immune cell-related genes in postmenopausal osteoporosis: An observational study.

Chen L, Zhao Y, Qiu J, Lin X Medicine (Baltimore). 2024; 103(19):e38042.

PMID: 38728482 PMC: 11081595. DOI: 10.1097/MD.0000000000038042.


References
1.
Osterhoff G, Morgan E, Shefelbine S, Karim L, McNamara L, Augat P . Bone mechanical properties and changes with osteoporosis. Injury. 2016; 47 Suppl 2:S11-20. PMC: 4955555. DOI: 10.1016/S0020-1383(16)47003-8. View

2.
Bonomo A, Monteiro A, Goncalves-Silva T, Cordeiro-Spinetti E, Galvani R, Balduino A . A T Cell View of the Bone Marrow. Front Immunol. 2016; 7:184. PMC: 4868947. DOI: 10.3389/fimmu.2016.00184. View

3.
Fassio A, Bertoldo F, Idolazzi L, Viapiana O, Rossini M, Gatti D . Drug-induced osteonecrosis of the jaw: the state of the art. Reumatismo. 2017; 69(1):9-15. DOI: 10.4081/reumatismo.2017.983. View

4.
Pandolfi F, Cianci R, Pagliari D, Landolfi R, Cammarota G . Cellular mediators of inflammation: tregs and TH17 cells in gastrointestinal diseases. Mediators Inflamm. 2010; 2009:132028. PMC: 2821644. DOI: 10.1155/2009/132028. View

5.
Walsh M, Choi Y . Biology of the RANKL-RANK-OPG System in Immunity, Bone, and Beyond. Front Immunol. 2014; 5:511. PMC: 4202272. DOI: 10.3389/fimmu.2014.00511. View